These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 15227615
1. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC. Clin Infect Dis; 2004 Jun 15; 38(12):1700-5. PubMed ID: 15227615 [Abstract] [Full Text] [Related]
2. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia? de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD. Diagn Mol Pathol; 2011 Sep 15; 20(3):184-8. PubMed ID: 21817905 [Abstract] [Full Text] [Related]
3. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Sakoulas G, Moellering RC, Eliopoulos GM. Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S40-50. PubMed ID: 16323119 [Abstract] [Full Text] [Related]
8. Association of biofilm formation and methicillin-resistance with accessory gene regulator (agr) loci in Greek Staphylococcus aureus clones. Ikonomidis A, Vasdeki A, Kristo I, Maniatis AN, Tsakris A, Malizos KN, Pournaras S. Microb Pathog; 2009 Dec 01; 47(6):341-4. PubMed ID: 19786085 [Abstract] [Full Text] [Related]
12. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. Denis O, Deplano A, De Beenhouwer H, Hallin M, Huysmans G, Garrino MG, Glupczynski Y, Malaviolle X, Vergison A, Struelens MJ. J Antimicrob Chemother; 2005 Dec 01; 56(6):1103-6. PubMed ID: 16223937 [Abstract] [Full Text] [Related]
13. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW. Diagn Microbiol Infect Dis; 2007 May 01; 58(1):41-7. PubMed ID: 17300912 [Abstract] [Full Text] [Related]
16. Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density. Tsuji BT, Harigaya Y, Lesse AJ, Sakoulas G, Mylotte JM. Diagn Microbiol Infect Dis; 2009 Jun 01; 64(2):220-4. PubMed ID: 19345040 [Abstract] [Full Text] [Related]
17. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study. Wang Z, Cao B, Liu YM, Gu L, Wang C. Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138 [Abstract] [Full Text] [Related]
18. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Moise PA, Sakoulas G, Forrest A, Schentag JJ. Antimicrob Agents Chemother; 2007 Jul 05; 51(7):2582-6. PubMed ID: 17452488 [Abstract] [Full Text] [Related]